Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562

Dexrazoxane combined with doxorubicin (+ 5-fluorouracil + cyclophosphamide – the FAC regime) leads to a significant decrease in doxorubicin cardiotoxicity and a significant increase in median survival time for patients with advanced breast cancer responsive to FAC. The reason for this increase in su...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargent, J M, Williamson, C J, Yardley, C, Taylor, C G, Hellmann, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363849/
https://www.ncbi.nlm.nih.gov/pubmed/11286477
http://dx.doi.org/10.1054/bjoc.2001.1697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363849/
https://www.ncbi.nlm.nih.gov/pubmed/11286477
http://dx.doi.org/10.1054/bjoc.2001.1697

Ejemplares similares